Literature DB >> 21838459

High-dose melphalan and autologous stem cell transplantation for AL amyloidosis: recent trends in treatment-related mortality and 1-year survival at a single institution.

D C Seldin1, N Andrea, I Berenbaum, J L Berk, L Connors, L M Dember, G Doros, S Fennessey, K Finn, S Girnius, A Lerner, C Libbey, H K Meier-Ewert, R O'Connell, C O'Hara, K Quillen, F L Ruberg, F Sam, A Segal, A Shelton, M Skinner, J M Sloan, J F Wiesman, V Sanchorawala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21838459      PMCID： PMC5601311          DOI： 10.3109/13506129.2011.574354047

Source DB:  PubMed          Journal:  Amyloid        ISSN： 1350-6129            Impact factor:   7.141


× No keyword cloud information.
  7 in total

1.  Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation.

Authors:  David C Seldin; Jennifer J Anderson; Vaishali Sanchorawala; Karim Malek; Daniel G Wright; Karen Quillen; Kathleen T Finn; John L Berk; Laura M Dember; Rodney H Falk; Martha Skinner
Journal:  Blood       Date:  2004-05-20       Impact factor: 22.113

2.  Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65.

Authors:  David C Seldin; Jennifer J Anderson; Martha Skinner; Karim Malek; Daniel G Wright; Karen Quillen; Kathleen Finn; Betul Oran; Vaishali Sanchorawala
Journal:  Blood       Date:  2006-08-22       Impact factor: 22.113

3.  Effect of dose-intensive intravenous melphalan and autologous blood stem-cell transplantation on al amyloidosis-associated renal disease.

Authors:  L M Dember; V Sanchorawala; D C Seldin; D G Wright; M LaValley; J L Berk; R H Falk; M Skinner
Journal:  Ann Intern Med       Date:  2001-05-01       Impact factor: 25.391

4.  Cardiac transplantation followed by dose-intensive melphalan and autologous stem-cell transplantation for light chain amyloidosis and heart failure.

Authors:  Bimalangshu R Dey; Stephen S Chung; Thomas R Spitzer; Hui Zheng; Thomas E Macgillivray; David C Seldin; Steven McAfee; Karen Ballen; Eyal Attar; Thomas Wang; Jordan Shin; Christopher Newton-Cheh; Stephanie Moore; Vaishali Sanchorawala; Martha Skinner; Joren C Madsen; Marc J Semigran
Journal:  Transplantation       Date:  2010-10-27       Impact factor: 4.939

5.  Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomes.

Authors:  S McDiarmid; B Hutton; H Atkins; I Bence-Bruckler; C Bredeson; E Sabri; L Huebsch
Journal:  Bone Marrow Transplant       Date:  2009-11-30       Impact factor: 5.483

6.  High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study.

Authors:  Martha Skinner; Vaishali Sanchorawala; David C Seldin; Laura M Dember; Rodney H Falk; John L Berk; Jennifer J Anderson; Carl O'Hara; Kathleen T Finn; Caryn A Libbey; Janice Wiesman; Karen Quillen; Niall Swan; Daniel G Wright
Journal:  Ann Intern Med       Date:  2004-01-20       Impact factor: 25.391

7.  High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal disease.

Authors:  Liam F Casserly; Amit Fadia; Vaishali Sanchorawala; David C Seldin; Daniel G Wright; Martha Skinner; Laura M Dember
Journal:  Kidney Int       Date:  2003-03       Impact factor: 10.612
  7 in total
  2 in total

1.  Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience.

Authors:  Andrew J Cowan; Martha Skinner; David C Seldin; John L Berk; David R Lichtenstein; Carl J O'Hara; Gheorghe Doros; Vaishali Sanchorawala
Journal:  Haematologica       Date:  2012-06-24       Impact factor: 9.941

2.  The Role of Kidney Transplantation in Monoclonal Ig Deposition Disease.

Authors:  Avital Angel-Korman; Lauren Stern; Yoel Angel; Shayna Sarosiek; Hanni Menn-Josephy; Jean Francis; Sandeep Ghai; J Mark Sloan; Vaishali Sanchorawala; Andrea Havasi
Journal:  Kidney Int Rep       Date:  2020-03-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.